Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lin-Yu Xia
Institutions:
Chengdu Medical College,
First Affiliated Hospital of Chengdu Medical College
Observed institutions:
Chengdu Medical College,
Tianjin Medical University Cancer Institute and Hospital,
First Affiliated Hospital of Chengdu Medical College,
Tianjin Medical University
ORCID:
0000-0003-4802-2359
Observed ORCID:
0000-0003-4802-2359
OpenAlex ID:
A5041468148
Survival outcomes of neoadjuvant versus adjuvant chemotherapy in triple-negative breast cancer: a meta-analysis of 36,480 cases
2020
·
Lin-Yu Xia
, Qing-Lin Hu
, et al.
·
World Journal of Surgical Oncology
·
59
PDF
Efficacy and Safety of Radiofrequency Ablation for Breast Cancer Smaller Than 2 cm: A Systematic Review and Meta-Analysis
2021
·
Lin-Yu Xia
, Qing-Lin Hu
, et al.
·
Frontiers in Oncology
·
34
PDF
Survival outcomes in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy: a meta-analysis
2024
·
Lin-Yu Xia
, Xu-Chen Cao
, et al.
·
World Journal of Surgical Oncology
·
19
PDF
Use of trastuzumab in treating breast cancer during pregnancy: a systematic review and meta-analysis
2021
·
Lin-Yu Xia
, Qing-Lin Hu
, et al.
·
BMC Women s Health
·
17
PDF
The different outcomes between breast-conserving surgery plus radiotherapy and mastectomy in metaplastic breast cancer: A population-based study
2021
·
Lin-Yu Xia
, Wei-Yun Xu
, et al.
·
PLoS ONE
·
16
PDF
Prognosis in HR-positive metastatic breast cancer with HER2-low versus HER2-zero treated with CDK4/6 inhibitor and endocrine therapy: a meta-analysis
2024
·
Lin-Yu Xia
, Xu-Chen Cao
, et al.
·
Frontiers in Oncology
·
12
PDF
Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer
2022
·
Lin-Yu Xia
, Wei-Yun Xu
, et al.
·
PLoS ONE
·
8
PDF
Survival outcomes after breast-conserving surgery plus radiotherapy compared with mastectomy in breast ductal carcinoma in situ with microinvasion
2022
·
Lin-Yu Xia
, Wei-Yun Xu
, et al.
·
Scientific Reports
·
5
PDF
Effect of HER2-low expression on the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer
2025
·
Lin-Yu Xia
, Xu-Chen Cao
, et al.
·
Scientific Reports
·
2
PDF
Discordance between Breast and Axillary Responses After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: Implications for Surgical De-Escalation
2026
·
Lin-Yu Xia
, Xu-Chen Cao
, et al.
·
Annals of Surgical Oncology
·
1
A pre-surgical decision-support nomogram for predicting nodal pathologic complete response after neoadjuvant therapy in patients with cN1-3 triple-negative breast cancer
2026
·
Lin-Yu Xia
, Xu-Chen Cao
, et al.
·
World Journal of Surgical Oncology
ASO Visual Abstract: Discordance Between Breast and Axillary Responses After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: Implications for Surgical De-escalation
2026
·
Lin-Yu Xia
, Xu-Chen Cao
, et al.
·
Annals of Surgical Oncology
ASO Author Reflections: Breast pCR is not the Whole Story: Rethinking Axillary Risk After Neoadjuvant Therapy in TNBC
2026
·
Lin-Yu Xia
·
Annals of Surgical Oncology
Show more works
View as search
Works count:
13
Citation count:
173
H-index:
7
I10-index:
6
Year
Topic
Type